{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syk kinase : Questions médicales les plus fréquentes",
"headline": "Syk kinase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syk kinase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-01",
"dateModified": "2025-04-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syk kinase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protein-tyrosine kinases",
"url": "https://questionsmedicales.fr/mesh/D011505",
"about": {
"@type": "MedicalCondition",
"name": "Protein-tyrosine kinases",
"code": {
"@type": "MedicalCode",
"code": "D011505",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syk kinase",
"alternateName": "Syk Kinase",
"code": {
"@type": "MedicalCode",
"code": "D000072377",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Andy Pike",
"url": "https://questionsmedicales.fr/author/Andy%20Pike",
"affiliation": {
"@type": "Organization",
"name": "DMPK (A.P., R.M., B.J.) and Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom andrew.pike@astrazeneca.com."
}
},
{
"@type": "Person",
"name": "Antonella Pantaleo",
"url": "https://questionsmedicales.fr/author/Antonella%20Pantaleo",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy."
}
},
{
"@type": "Person",
"name": "Jinhua Wang",
"url": "https://questionsmedicales.fr/author/Jinhua%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA."
}
},
{
"@type": "Person",
"name": "Jae Youl Cho",
"url": "https://questionsmedicales.fr/author/Jae%20Youl%20Cho",
"affiliation": {
"@type": "Organization",
"name": "Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, 16419, Republic of Korea; Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon, 16419, Republic of Korea; Department of Biocosmetics, Sungkyunkwan University, Suwon 16419, Republic of Korea. Electronic address: jaecho@skku.edu."
}
},
{
"@type": "Person",
"name": "Bernard Barlaam",
"url": "https://questionsmedicales.fr/author/Bernard%20Barlaam",
"affiliation": {
"@type": "Organization",
"name": "R&D Oncology, AstraZeneca, Cambridge, United Kingdom. Electronic address: Bernard.barlaam2@astrazeneca.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Artificial visual perception neural system using a solution-processable MoS",
"datePublished": "2023-05-05",
"url": "https://questionsmedicales.fr/article/37147334",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41377-023-01166-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma.",
"datePublished": "2023-05-02",
"url": "https://questionsmedicales.fr/article/37142176",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajo.2023.04.017"
}
},
{
"@type": "ScholarlyArticle",
"name": "Computed Tomography Neurography for Visualization of the In Vivo Nervous System: A Proof of Concept.",
"datePublished": "2023-04-19",
"url": "https://questionsmedicales.fr/article/37077126",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/15589447231164735"
}
},
{
"@type": "ScholarlyArticle",
"name": "Visual policy narrative messaging improves COVID-19 vaccine uptake.",
"datePublished": "2023-04-18",
"url": "https://questionsmedicales.fr/article/37096197",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/pnasnexus/pgad080"
}
},
{
"@type": "ScholarlyArticle",
"name": "Acute visual change as first symptom of B-cell prolymphocytic leukaemia.",
"datePublished": "2023-04-14",
"url": "https://questionsmedicales.fr/article/37054461",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protein-tyrosine kinases",
"item": "https://questionsmedicales.fr/mesh/D011505"
},
{
"@type": "ListItem",
"position": 6,
"name": "Syk kinase",
"item": "https://questionsmedicales.fr/mesh/D000072377"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syk kinase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syk kinase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syk kinase",
"description": "Comment diagnostiquer une dysfonction de la Syk kinase ?\nQuels tests sont utilisés pour évaluer l'activité de la Syk kinase ?\nY a-t-il des biomarqueurs associés à la Syk kinase ?\nQuels symptômes peuvent indiquer un problème avec la Syk kinase ?\nLa Syk kinase est-elle impliquée dans des maladies spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D000072377?mesh_terms=Pattern+Recognition,+Visual&page=998#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syk kinase",
"description": "Quels symptômes sont liés à une activation excessive de la Syk kinase ?\nLa Syk kinase affecte-t-elle le système immunitaire ?\nQuels signes cliniques peuvent indiquer une dysfonction de la Syk kinase ?\nLes troubles de la Syk kinase provoquent-ils des symptômes neurologiques ?\nY a-t-il des symptômes associés à des inhibiteurs de la Syk kinase ?",
"url": "https://questionsmedicales.fr/mesh/D000072377?mesh_terms=Pattern+Recognition,+Visual&page=998#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syk kinase",
"description": "Peut-on prévenir les dysfonctionnements de la Syk kinase ?\nY a-t-il des mesures préventives pour les maladies liées à la Syk kinase ?\nLes vaccinations influencent-elles la Syk kinase ?\nComment le stress affecte-t-il la Syk kinase ?\nL'exercice physique influence-t-il la Syk kinase ?",
"url": "https://questionsmedicales.fr/mesh/D000072377?mesh_terms=Pattern+Recognition,+Visual&page=998#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syk kinase",
"description": "Quels traitements ciblent la Syk kinase ?\nLes traitements de la Syk kinase sont-ils efficaces ?\nQuels médicaments inhibent la Syk kinase ?\nY a-t-il des effets secondaires des traitements de la Syk kinase ?\nComment les traitements de la Syk kinase sont-ils administrés ?",
"url": "https://questionsmedicales.fr/mesh/D000072377?mesh_terms=Pattern+Recognition,+Visual&page=998#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syk kinase",
"description": "Quelles complications peuvent survenir avec une dysfonction de la Syk kinase ?\nLa Syk kinase est-elle liée à des cancers ?\nQuels risques sont associés aux inhibiteurs de la Syk kinase ?\nLes complications de la Syk kinase affectent-elles la qualité de vie ?\nY a-t-il des complications neurologiques liées à la Syk kinase ?",
"url": "https://questionsmedicales.fr/mesh/D000072377?mesh_terms=Pattern+Recognition,+Visual&page=998#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syk kinase",
"description": "Quels sont les facteurs de risque pour les maladies liées à la Syk kinase ?\nLe tabagisme affecte-t-il la Syk kinase ?\nL'alimentation influence-t-elle la Syk kinase ?\nLe stress est-il un facteur de risque pour la Syk kinase ?\nY a-t-il des prédispositions génétiques liées à la Syk kinase ?",
"url": "https://questionsmedicales.fr/mesh/D000072377?mesh_terms=Pattern+Recognition,+Visual&page=998#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction de la Syk kinase ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses de sang peuvent aider à diagnostiquer des anomalies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité de la Syk kinase ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des dosages de protéines spécifiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des biomarqueurs associés à la Syk kinase ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biomarqueurs comme le phospho-Syk peuvent indiquer son activation."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec la Syk kinase ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes immunitaires ou inflammatoires peuvent suggérer une dysfonction."
}
},
{
"@type": "Question",
"name": "La Syk kinase est-elle impliquée dans des maladies spécifiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est liée à des maladies auto-immunes et des cancers."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une activation excessive de la Syk kinase ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une activation excessive peut entraîner des inflammations et des douleurs articulaires."
}
},
{
"@type": "Question",
"name": "La Syk kinase affecte-t-elle le système immunitaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle joue un rôle clé dans la régulation des réponses immunitaires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques peuvent indiquer une dysfonction de la Syk kinase ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des infections fréquentes ou des réactions allergiques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les troubles de la Syk kinase provoquent-ils des symptômes neurologiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien potentiel, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés à des inhibiteurs de la Syk kinase ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets secondaires comme des nausées ou des infections peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les dysfonctionnements de la Syk kinase ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à maintenir la santé immunitaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour les maladies liées à la Syk kinase ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les facteurs de risque comme le tabagisme peut réduire les maladies associées."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles la Syk kinase ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent moduler l'activité de la Syk kinase dans le système immunitaire."
}
},
{
"@type": "Question",
"name": "Comment le stress affecte-t-il la Syk kinase ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut altérer la signalisation de la Syk kinase, affectant l'immunité."
}
},
{
"@type": "Question",
"name": "L'exercice physique influence-t-il la Syk kinase ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la fonction immunitaire et la signalisation de Syk."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent la Syk kinase ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs de Syk sont utilisés pour traiter certaines maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les traitements de la Syk kinase sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils montrent des résultats prometteurs dans le contrôle des maladies inflammatoires."
}
},
{
"@type": "Question",
"name": "Quels médicaments inhibent la Syk kinase ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme le fostamatinib sont des inhibiteurs spécifiques de Syk."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des traitements de la Syk kinase ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets comme des troubles gastro-intestinaux et des infections peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les traitements de la Syk kinase sont-ils administrés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être administrés par voie orale ou intraveineuse, selon le médicament."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une dysfonction de la Syk kinase ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des infections récurrentes et des maladies auto-immunes peuvent survenir."
}
},
{
"@type": "Question",
"name": "La Syk kinase est-elle liée à des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activation anormale de Syk est associée à certains types de cancers."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés aux inhibiteurs de la Syk kinase ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les inhibiteurs peuvent augmenter le risque d'infections et de troubles hématologiques."
}
},
{
"@type": "Question",
"name": "Les complications de la Syk kinase affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent gravement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications neurologiques liées à la Syk kinase ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours pour explorer les liens entre Syk et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les maladies liées à la Syk kinase ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'âge, le sexe et des antécédents familiaux peuvent influencer le risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il la Syk kinase ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut altérer la signalisation de la Syk kinase et augmenter les risques de maladies."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la Syk kinase ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants peut aider à réguler l'activité de la Syk kinase."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque pour la Syk kinase ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut exacerber les dysfonctionnements de la Syk kinase."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques liées à la Syk kinase ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines variations génétiques peuvent augmenter le risque de dysfonctionnement de Syk."
}
}
]
}
]
}
Optoelectronic devices are advantageous in in-memory light sensing for visual information processing, recognition, and storage in an energy-efficient manner. Recently, in-memory light sensors have bee...
To evaluate the association between baseline severity of visual field (VF) damage and the initial rates of VF progression with quality of life (QOL) outcomes over an extended follow-up in glaucoma....
Retrospective cohort study....
Both eyes of 167 glaucoma or suspected glaucoma patients were followed for 10.0±0.3 years. The National Eye Institute Visual Function Questionnaire (NEI-VFQ)-25 was performed at the end of the follow-...
All models demonstrated association of worse baseline severity of VF damage with worse subsequent NEI-VFQ-25 scores. Faster rates of decline in VF mean deviation of the better eye and the mean sensiti...
Baseline severity and initial rates of change of VF damage are associated with QOL outcomes over an extended follow-up. Assessment of longitudinal VF changes, especially in better eye, provides progno...
The human peripheral nervous system embodies anatomical, physiologic, and diagnostic perplexities that remain unexplained. Yet in the course of human history, there are no mechanisms, such as computed...
A novel class of contrast was created by linking iodine to lidocaine. The radiodensity of 0.5% experimental contrast molecule was compared with a control of 1% lidocaine by placing 1.5-mL aliquots of ...
The mean Hounsfield unit of the contrast was 56.09 compared with -0.48 for control (116-fold increase,...
Iodinated lidocaine offers a viable mechanism for in vivo peripheral nerve imaging using CT; however, it requires modification to improve in vivo radiodensity....
In the face of vaccine hesitancy, public health officials are seeking more effective risk communication approaches to increase vaccination rates. We test the influence of visual policy narratives on C...
A large body of work has linked neural oscillations in the alpha-band (8-13 Hz) to visual perceptual outcomes. In particular, studies have found that alpha phase prior to stimulus onset predicts stimu...
To enable interactive visualization of phenome-wide association studies (PheWAS) on electronic health records (EHR)....
Current PheWAS technologies require familiarity with command-line interfaces and lack end-to-end data visualizations. pyPheWAS Explorer allows users to examine group variables, test assumptions, desig...
A cohort of attention deficit hyperactivity disorder (ADHD) subjects and matched non-ADHD controls is examined. pyPheWAS Explorer is used to build a PheWAS model including sex and deprivation index as...
pyPheWAS Explorer may be used to rapidly investigate potentially novel EHR associations. Broader applications include deployment for clinical experts and preliminary exploration tools for institutiona...
pyPheWAS Explorer provides a seamless graphical interface for designing, executing, and analyzing PheWAS experiments, emphasizing exploratory analysis of regression types and covariate selection....
Deep neural networks (DNNs) are machine learning algorithms that have revolutionized computer vision due to their remarkable successes in tasks like object classification and segmentation. The success...
Embodied PointGoal navigation is a fundamental task for embodied agents. Recent works have shown that the performance of the embodied navigation agent degrades significantly in the presence of visual ...
Aberrantly slow mRNA translation leads to ribosome stalling and subsequent collision with the trailing neighbor. Ribosome collisions have recently been shown to act as stress sensors in the cell, with...